跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME
Authorized
STANDARD
ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME
laboratoires trianon inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e0029e885664edb4
Company
laboratoires trianon inc.
Type
Standard
Approval Details
Approval Id
e0029e885664edb4
Drug Approval Canada Name
ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME
Product Name
ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME
Status
Marketed
Status Date
2018-02-23
Original Market Date
2018-02-23
Din
02238183
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
04:04.04
Atc Original
N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS
Atc Name
n 02 be 51
Aig Number
0233808001
Company Name
laboratoires trianon inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
ACETAMINOPHEN
500 MG
DIPHENHYDRAMINE HYDROCHLORIDE
25 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e0029e885664edb4
Type
Standard
Back to Health Canada Approvals